Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Histocompatibility and Donor Selection Issues

Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: A new prospect of exploiting extended family search

Bone Marrow Transplantation volume 50, pages 545–552 (2015)Cite this article

Subjects

Abstract

The best donors for hematopoietic SCT (HSCT) are fully-matched siblings. In patients without fully-matched siblings, HLA registries or cord blood banks are alternative strategies with some restrictions. Owing to the high rate of consanguineous marriage in our country, between 2006 and 2013, extended family searches were undertaken in Hematology-Oncology Research Center and Stem Cell Transplantation (HORCSCT), Tehran, Iran, in 523 HSCT candidates with parental consanguinity and no available HLA identical sibling. Fully-matched other-relative donors were found for 109 cases. We retrospectively studied the HSCT outcome in these patients. Median time to neutrophil engraftment was 13 days (range: 9–31days). In 83 patients, full chimerism and in 17 patients, mixed chimerism was achieved. Acute GvHD (aGvHD) grade II–IV appeared in 36 patients (33%). The frequency of aGvHD development in various familial subgroups was NS. Five patients expired before day+100. In the surviving 104 cases, chronic GvHD developed in 20 patients (19.2%). The distantly related subgroup had significantly a higher rate of cGvHD (P=0.04). The 2-year OS and disease-free survival (DFS) were 76.7±4.5% and 71.7±4.7%, respectively. No significant difference in OS (P=0.30) and DFS (P=0.80) was unraveled between various familial relationships. Our considerable rate of fully-matched non-sibling family members and the favorable outcome support the rationale for extended family search in regions where consanguineous marriage is widely practiced.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Samuel GN, Kerridge IH, O’Brien TA . Umbilical cord blood banking: public good or private benefit? Med J Aust 2008; 188: 533–535.

    PubMed  Google Scholar 

  2. Cairo MS, Rocha V, Gluckman E, Hale G, Wagner J . Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors. Biol Blood Marrow Transplant 2008; 14: 44–53.

    Article  PubMed  Google Scholar 

  3. Rafeah NT, Fadilah SA . The A-B-C of haematopoietic stem cell transplantation. Med J Malaysia 2009; 64: 94–100.

    CAS  PubMed  Google Scholar 

  4. Filipovich AH, Stone JV, Tomany SC, Ireland M, Kollman C, Pelz CJ et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598–1603.

    Article  CAS  PubMed  Google Scholar 

  5. van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W et al. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1997; 20: 553–560.

    Article  CAS  PubMed  Google Scholar 

  6. Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991–2000). Blood 2003; 102: 1541–1547.

    Article  CAS  PubMed  Google Scholar 

  7. Souillet G, Rey S, Bertrand Y, Pujol M, Pondarre C, Bourgeot JP et al. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation. Bone Marrow Transplant 2000; 26: 31–43.

    Article  CAS  PubMed  Google Scholar 

  8. Kumar P, Defor TE, Brunstein C, Barker JN, Wagner JE, Weisdorf DJ et al. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. Biol Blood Marrow Transplant 2008; 14: 1394–1400.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Camitta B, Ash R, Menitove J, Murray K, Lawton C, Hunter J et al. Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. Blood 1989; 74: 1852–1857.

    CAS  PubMed  Google Scholar 

  10. Petersdorf EW . Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 2008; 20: 588–593.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Enczmann J, Rinker M, Kiesel U, Kuhrober A, Kogler G, Nurnberger W et al. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Dusseldorf (1997–1998). Klin Padiatr 1999; 211: 218–223.

    Article  CAS  PubMed  Google Scholar 

  12. Rocha V, Locatelli F . Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008; 41: 207–214.

    Article  CAS  PubMed  Google Scholar 

  13. Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J . Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood 2012; 119: 3908–3916.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 2006; 24: 145–151.

    Article  PubMed  Google Scholar 

  15. Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol 2009; 27: 1644–1652.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Warwick R, Armitage S . Cord blood banking. Best Pract Res Clin Obstet Gynaecol 2004; 18: 995–1011.

    Article  PubMed  Google Scholar 

  17. Schipper RF, D'Amaro J, Oudshoorn M . The probability of finding a suitable related donor for bone marrow transplantation in extended families. Blood 1996; 87: 800–804.

    CAS  PubMed  Google Scholar 

  18. Hurley CK, Wagner JE, Setterholm MI, Confer DL . Advances in HLA: practical implications for selecting adult donors and cord blood units. Biol Blood Marrow Transplant 2006; 12: 28–33.

    Article  PubMed  Google Scholar 

  19. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.

    Article  PubMed  Google Scholar 

  20. Ballen K . Challenges in umbilical cord blood stem cell banking for stem cell reviews and reports. Stem Cell Rev 2010; 6: 8–14.

    Article  Google Scholar 

  21. Louw VJ, Heyns Adu P . The role of the state in establishing a public cord blood stem cell bank. S Afr Med J 2010; 100: 292–294.

    Article  PubMed  Google Scholar 

  22. Balci YI, Tavil B, Tan CS, Ozgur TT, Bulum B, Cetin M et al. Increased availability of family donors for hematopoietic stem cell transplantation in a population with increased incidence of consanguinity. Clin Transplant 2011; 25: 475–480.

    Article  PubMed  Google Scholar 

  23. Maiers M, Gragert L, Madbouly A, Steiner D, Marsh SG, Gourraud PA et al. 16(th) IHIW: global analysis of registry HLA haplotypes from 20 million individuals: report from the IHIW Registry Diversity Group. Int J Immunogenet 2013; 40: 66–71.

    CAS  PubMed  Google Scholar 

  24. Lown RN, Marsh SG, Switzer GE, Latham KA, Madrigal JA, Shaw BE . Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage. Bone Marrow Transplant 2014; 49: 525–531.

    Article  CAS  PubMed  Google Scholar 

  25. Israeli M, Yeshurun M, Stein J, Ram R, Shpilberg O, Levi CL et al. Trends and challenges in searching for HLA-matched unrelated donors in Israel. Hum Immunol 2013; 74: 942–945.

    Article  PubMed  Google Scholar 

  26. Ottinger H, Grosse-Wilde M, Schmitz A, Grosse-Wilde H . Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant 1994; 14: S34–S38.

    PubMed  Google Scholar 

  27. Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK et al. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report. Bone Marrow Transplant 2009; 43: 1–12.

    Article  CAS  PubMed  Google Scholar 

  28. Sheth K, Elkhalifa M, Kelly T, Sahovic E . What are the chances of finding related HLA match donors for allogeneic BMT recipients in Saudi Arabia? Blood 1996; 88: 265b.

    Google Scholar 

  29. Shamsi T, Hashmi K, Adil S, Ahmad P, Irfan M, Raza S et al. The stem cell transplant program in Pakistan—the first decade. Bone Marrow Transplant 2008; 42: S114–S117.

    Article  PubMed  Google Scholar 

  30. Sierra J, Storer B, Hansen JA, Bjerke JW, Martin PJ, Petersdorf EW et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997; 89: 4226–4235.

    CAS  PubMed  Google Scholar 

  31. Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 1767–1777.

    CAS  PubMed  Google Scholar 

  32. Geller RB, Devine SM, O’Toole K, Persons L, Keller J, Mauer D et al. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation. Bone Marrow Transplant 1997; 20: 219–225.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Perkins HA, Kollman C, Howe CW . Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program. Clin Transpl 1994, 295–301.

  34. Jaber L, Halpern GJ, Shohat M . The impact of consanguinity worldwide. Community Genet 1998; 1: 12–17.

    CAS  PubMed  Google Scholar 

  35. Abdulrazzaq YM, Bener A, al-Gazali LI, al-Khayat AI, Micallef R, Gaber T . A study of possible deleterious effects of consanguinity. Clin Genet 1997; 51: 167–173.

    Article  CAS  PubMed  Google Scholar 

  36. Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA . Consanguinity and reproductive health among Arabs. Reprod Health 2009; 6: 17.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Klein T, Yaniv I, Stein J, Narinsky R, Finkelstein Y, Garty BZ . Extended family studies for the identification of allogeneic stem cell transplant donors in Jewish and Arabic patients in Israel. Pediatr Transplant 2005; 9: 52–55.

    Article  CAS  PubMed  Google Scholar 

  38. Goker H, Ozdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S et al. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience. Transfus Apher Sci 2013; 49: 590–599.

    Article  PubMed  Google Scholar 

  39. Litzow MR, Tarima S, Perez WS, Bolwell BJ, Cairo MS, Camitta BM et al. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 2010; 115: 1850–1857.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Walter RB, Pagel JM, Gooley TA, Petersdorf EW, Sorror ML, Woolfrey AE et al. Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission. Leukemia 2010; 24: 1276–1282.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M et al. Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012; 18: 1204–1210.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A et al. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer 2009; 53: 1289–1294.

    Article  PubMed  Google Scholar 

  43. Yesilipek MA, Ertem M, Cetin M, Oniz H, Kansoy S, Tanyeli A et al. HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: the experience of the Turkish Pediatric Bone Marrow Transplantation Group. Pediatr Transplant 2012; 16: 846–851.

    Article  PubMed  Google Scholar 

  44. Li CK, Shing MM, Chik KW, Lee V, Leung TF, Cheung AY et al. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome. Bone Marrow Transplant 2002; 29: 101–105.

    Article  CAS  PubMed  Google Scholar 

  45. Hamidieh AA, Alimoghaddam K, Jahani M, Bahar B, Mousavi SA, Iravani M et al. Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience. J Pediatr Hematol Oncol 2013; 35: e239–e245.

    Article  CAS  PubMed  Google Scholar 

  46. Schultz KR, Carroll A, Heerema NA, Bowman WP, Aledo A, Slayton WB et al. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031. Leukemia 2014; 28: 1467–1471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Nagler A, Labopin M, Berger R, Bunjes D, Campos A, Socie G et al. Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome. Bone Marrow Transplant 2014; 49: 628–633.

    Article  CAS  PubMed  Google Scholar 

  48. Al-Kadhimi Z, Gul Z, Chen W, Smith D, Abidi M, Deol A et al. High incidence of severe acute graft-versus-host disease with tacrolimus and mycophenolate mofetil in a large cohort of related and unrelated allogeneic transplantation patients. Biol Blood Marrow Transplant 2014; 20: 979–985.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K et al. Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Biol Blood Marrow Transplant 2014; 20: 662–667.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Li XH, Gao CJ, Da WM, Cao YB, Wang ZH, Xu LX et al. Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia. PLoS One 2014; 9: e89666.

    Article  PubMed  PubMed Central  Google Scholar 

  51. El‐Cheikh J, Vazquez A, Crocchiolo R, Furst S, Calmels B, Castagna L et al. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation. Am J Hematol 2012; 87: 1074–1078.

    Article  PubMed  Google Scholar 

  52. Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E et al. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol 2009; 144: 933–945.

    Article  CAS  PubMed  Google Scholar 

  53. Marsh JC, Gupta V, Lim Z, Ho AY, Ireland RM, Hayden J et al. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood 2011; 118: 2351–2357.

    Article  CAS  PubMed  Google Scholar 

  54. Kang HJ, Shin HY, Park JE, Chung NG, Cho B, Kim HK et al. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study. Biol Blood Marrow Transplant 2010; 16: 1582–1588.

    Article  CAS  PubMed  Google Scholar 

  55. O'Meara A, Holbro A, Meyer S, Martinez M, Medinger M, Buser A et al. Forty years of haematopoietic stem cell transplantation: a review of the Basel experience. Swiss Med Wkly 2014; 144: w13928.

    PubMed  Google Scholar 

  56. Mateos MK, O'Brien TA, Oswald C, Gabriel M, Ziegler DS, Cohn RJ et al. Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review. Pediatr Blood Cancer 2013; 60: 1520–1527.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007; 92: 11–18.

    Article  CAS  PubMed  Google Scholar 

  58. Vowels MR, Honeyman M, Ziegler JB, White L, Doran T, Lam-Po-Tang R . Searches for matched and closely matched related and unrelated bone marrow donors undertaken in a single paediatric unit. J Paediatr Child Health 1992; 28: 379–382.

    Article  CAS  PubMed  Google Scholar 

  59. Varla-Leftherioti M, Schipper R, Keramitosoglou T, Kozoni S, Oudshoorn M . Probability of finding extended family donors for greak patients in need of a bone marrow transplant. Haematol 1998; 3: 132–137.

    Google Scholar 

  60. Perez LE . Outcomes from unrelated donor hematopoietic stem cell transplantation. Cancer Control 2011; 18: 216–221.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge the patients who participated in this study and the Hematology, Oncology and Stem Cell Transplantation Research Center nursing staff.

Author information

Authors and Affiliations

  1. Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of MedicalSciences, Tehran, Iran

    A A Hamidieh, M Ostadali Dehaghi, P Paragomi, S Navaei, A Jalali, G Ghazizadeh Eslami, M Behfar & A Ghavamzadeh

Authors
  1. A A Hamidieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Ostadali Dehaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Paragomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Navaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Jalali
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Ghazizadeh Eslami
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Behfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Ghavamzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A A Hamidieh.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamidieh, A., Dehaghi, M., Paragomi, P. et al. Efficiency of allogeneic hematopoietic SCT from HLA fully-matched non-sibling relatives: A new prospect of exploiting extended family search. Bone Marrow Transplant 50, 545–552 (2015). https://doi.org/10.1038/bmt.2014.307

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.307

This article is cited by

Search

Advanced search

Quick links